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ABSTRACT
Development of a Novel Bioprinting System:
Bioprinter, Bioink, Characterization
and Optimization
Chandler Alan Warr
Department of Chemical Engineering, BYU
Master of Science

The use of 3D printing in biological applications is a new field of study given that 3D
printing technology has become more available and user friendly. Possible uses include using
existing 3D printing polymers to use in extracorporeal or in vitro devices, like Lab-on-a-Chip,
and the development of new biologically derived materials to print cell-containing constructs. The
latter concept is what is more commonly known as bioprinting. Our research had the goal of
developing a bioprinting system including the printer, a bioink, and a feedback system for printing
parameter optimization which could be done cheaply and within the reach of nearly any research
lab. To make the bioprinter, we were able to take a popular plastic 3D printer and convert it to
a bioprinter with 3D printed parts and the addition of a new motherboard. This came with great
contribution from Carnegie Melon University. We were also able to improve upon the original
design and, along with the new bioprinting capabilities, maintain the original capabilities of the
plastic 3D printer. A new bioink was developed to work in coordination with this bioprinting
system. Our lab has the luxury of having access to decellularized tissue, which provided a unique
material to create a bioink which is derived from the extra-cellular matrix of porcine hearts. The
final bioink protocol allows the users to make their own bioink, from easily obtainable tissue and
determine their own concentration of the extra-cellular matrix/collagen within a range. Lastly,
a feedback system was developed using a Raspberry Pi and camera module to provide real-time
visual feedback of the bioprinting process which is otherwise very difficult to see and optimize
parameters from. A protocol was developed to sequentially optimize the parameters for an opensource slicing software which governs the resolution of the bioprinter itself. In related research,
the cytotoxicity and cell adherence properties of a printing resin for a microfluidic 3D printer were
evaluated for use in Lab-on-a-Chip applications. The existing resin was tested and determined to
be cytotoxic to cells and therefore not suitable for biological applications. We showed that a simple
ethanol washing step and plasma treatment pulled the cytotoxic elements out of the polymer and
modified the surface such that cells could attach and proliferate on the printed resin. Another
printed resin was also tested which was determined to have no natural cytotoxicity, but the same
plasma treatment was needed to allow for cell adherence.
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CHAPTER 1.

INTRODUCTION AND BACKGROUND

In the early 1990s researchers from MIT and Harvard keyed the phrase ”Tissue Engineering” as the development of biological substitutes to aid the body in regeneration, which blended
the fields of cellular biology and engineering [1]. Since then, tissue engineering has grown and
developed with new technologies and applications. Current successes in tissue engineering include MIRODERM from Miromatrix Medical Inc., (Eden Prairie, MN) an acellular wound matrix for surface application, and growth factors for bone regeneration (INFUSE Bone Graft from
Medtronic, Minneapolis, MN). Cellular versus acellular and in vivo versus in vitro development
of constructs continues to be a topic of research and discussion [2]. Recent discussion in tissue
engineering revolves around bioprinting and methods of using this technology to further the field
of tissue engineering.
Bioprinting, a derivative of traditional 3D printing, has the capability of quickly producing
constructs structurally similar to living tissue that cannot be produced using other manufacturing
methods. The development of a bioprinting system capable of reproducing a vascularized tissue
could be the answer to the current organ shortage. This thesis will address the development of bioprinting systems to be used in biomedical applications including a novel fused deposition modeling
(FDM) style bioprinter and a stereolithography (SLA) bioprinter and resin that have been developed previously. Given the complexity of bioprinting, which includes the printer types, material
selection, cross-linking methods, substrate support baths, and print characterization, this introduction will provide a brief background on these topics to give the reader needed context.

1

1.1
1.1.1

3D Printing
Additive Manufacturing
Three dimensional (3D) printing is a form of additive manufacturing which is the process of

progressively adding material to form a desired structure. This contrasts with standard subtractive
manufacturing where material is taken away from a bulk to give the desired structure. Subtractive
manufacturing is the most common manufacturing method, but it is limited in the designs it can
manufacture. Additive manufacturing however, can create much more intricate designs, or designs
that are impossible to build through subtractive manufacturing, by building a design up layer by
layer. The process of additive manufacturing has become more popular in the form of 3D printing.
It is now a fairly simple process to either buy and operate, or make a 3D printer to use at home; it
is also becoming a more common manufacturing method in industrial applications. Generally, 3D
printing can be broken down into two different categories; DLP/SLA printing (SLA) also known as
stereolithography printing and fused-deposition modeling (FDM) printing. Both print using a 3D
modeling file operated by slicing software to provide the printer with 2D slices of the model that
print layer upon layer. SLA printing consists of an upside-down print bed which is lowered into a
liquid resin. The resin is then photo cross-linked with a light source in the pattern desired for that
particular layer. FDM printers use essentially a hot-glue gun which extrudes melted plastic into
the desired pattern for that layer and is quickly cooled prior to the next layer being printed. SLA
printing can reach a resolution of around 20 to 100 µm with harder materials that don’t move layer
upon layer. FDM printers have a wide range of resolutions that can go down to a motor resolution
of about 100 µm using a variety of materials including PLA, ABS, and other thermoset polymers.
Bioprinting is a derivative of traditional 3D printing where the main difference is in the
extrusion method. SLA style bioprinters have almost no difference from their traditional counterparts except that material properties will be optimized for biological conditions and cellular contact. FDM style bioprinters have more significant differences from traditional printers of this kind
and tend to use a syringe and needle to extrude the paste-like material that is printed. The material
properties of this paste, as well as the printer accuracy and needle gauge, help to determine the
resolution of the printed constructs. The combined resolution of the printer, needle, and material
properties determine what designs can be reliably printed. For instance, if a printer has accuracy
2

down to 100 µm and a 30-gauge needle is used, which has an internal diameter of 160 µm, then
it would be impossible to print a wall 120 µm thick. Even though the motor resolution is below
120 µm, the width of the needle precludes the desired print resolution. The overall resolution of a
printed construct is also dependent on material properties; if a material has a high viscosity, it may
not be possible to extrude it at the desired rate for printing. Both SLA and FDM style bioprinters
have potential for use in biomedical applications if the material properties and resolution can be
optimized for biological conditions.

1.1.2

Printing Substrates
FDM-style bioprinters extruding pastes need, in most cases, a substrate support bath to

print into since the extruded paste cannot support itself layer upon layer. Imagine trying to print a
cube out of toothpaste; the end product would just be a pile of toothpaste in a sort of square. Pastes
need to be suspended in a printing substrate while they are liquid and then cross-linked or solidified
by various means into their final desired shape. Now imagine printing a toothpaste cube from a
needle inside of hair gel. This allows for any shape to be printed, even ones that are not possible
by traditional 3D printing, since any given layer being printed doesn’t depend on the previous
layer printed underneath it for support. One method of doing this is to use a carbomer polymer
support gel, similar to hair gel [3] . Another method referred to as Freeform Reversible Embedded
Suspension of Hydrogels (FRESH) uses a gelatin slurry, blended to a specified polymer chain
length, to create a shear-thinning gel which can be used as a printing substrate. [4] This method is
particularly useful in bioprinting because it can be liquified in an incubator at 37 °C from which
you can easily remove the printed construct. However, the method of printing within a substrate
creates problems not seen in traditional 3D printing. One problem is that of the additional drag
created by the printing needle moving through a fluid viscous enough to hold the print material
in suspension. This can be helped by tuning the printing substrate to be shear-thinning, but this
can’t be done with all substrates. Therefore, the printing material and substrate properties need to
be optimized together to ensure that the print design can be printed consistently and predictably.
There are some materials and methods that don’t require a printing substrate, however, these are
limited in use currently.

3

1.1.3

Characterization and Printing Parameters
One of the most difficult aspects of bioprinting is the characterization of the prints, ensur-

ing that the design sent to the printer is actually being produced by the printer. Traditional 3D
printing has printing parameters that are optimized using visual feedback. This feedback has been
standardized using a benchmark print known as Benchy. This print, which happens to look like
a boat, is designed to be difficult to print and provides feedback on the resolution of a particular
printer and material combination. This characterization becomes more difficult in extrusion bioprinting because the extrusion must be done within a suspension substrate and visual feedback
cannot be relied upon while the print is in suspension. Constructs that have been cured and pulled
out of suspension can give feedback for printing parameters, but it is possible that the curing process could swell or shrink the construct and provide false data. These data are needed in order to
optimize printing parameters such as extrusion width and height, overlap, and extrusion multiplier.
The inability to optimize these parameters to the micron level is a problem yet to be addressed in
detail and will be discussed in Chapter 4.

1.2
1.2.1

Material Characteristics
Material Options
SLA printing technology currently works with many different materials and photoinitiators,

generally using polymer resins which can mimic the feel of materials such as polypropylene, clear
polycarbonate, and rubber. SLA printer materials are generally limited by the photoinitiated curing
method but must also have a low viscosity such that the print platform can be quickly cleared of
uncured resin. The types of materials used in SLA printing may be very useful for biomedical devices, both implantable and extracorporeal, but may not be as useful for cell-laden tissue scaffolds.
On the other hand, FDM bioprinter materials range from native bioinks like collagen and fibrin, to
alginate and other hydrogels, and even silicon rubber. These materials can be cross-linked using
multiple methods including photo, catalytic, chemical, and thermal cross-linking depending on the
material. This gives flexibility to the material selection since materials can be mixed at different
ratios and optimized for various applications. However, one necessary property of these extruded
materials is that they are thin enough to be extruded through a needle small enough to maintain
4

good print resolution. This means that high-viscosity materials require a larger needle which results in a lower resolution. If higher resolutions are desired, smaller needles or a shear-thinning
material must be used.

1.2.2

Biocompatibility
A final property to consider regarding bioprinting materials is that of biocompatibility.

Biocompatibility needs will differ depending on the purpose of the printed construct; whether it is
an acellular extracorporeal device, an acellular implanted device, or intended as a cell-laden tissue
scaffold. Overall, bioprinted constructs need to be nontoxic to cells, which may require post-print
processing, and not have an inherent immune response when implanted. Additionally, since almost
all bioprinted constructs will be blood contacting, they need to have non-thrombogenic properties
that will minimize clotting within the construct. Non-thrombogenic properties can, however, be
introduced during post-processing with surface modifications, such as a heparin coating, if they are
not inherent within the material. Lastly, if the intent of the construct is for tissue generation, then
the use of native materials, materials such as collagen and fibrin which are naturally occurring in
the body, becomes increasingly important as those will likely be more easily remodeled by inlaid
cells.

5

CHAPTER 2.

2.1
2.1.1

BIOPRINTER MECHANICAL AND ELECTRICAL MODIFICATION

Background
Additive Manufacturing
Many different methods of additive manufacturing are available to researchers worldwide

to investigate possible applications within tissue engineering. These include electrospinning, lamination, and various methods of 3D printing as researchers have looked into methods to manufacture
an in vivo vasculature [5, 6]. Bioprinting has sparked recent interest because of its ability to build
complex structures and the variety of usable materials that are available. Various methods of bioprinting have been examined in detail by many different researchers in evaluating printing methods
with their associated resolution and advantages [7–9]. Generally, SLA and FDM style bioprinters are most common and seem to have the highest probability of producing viable tissues and
extracorporeal/implantable devices.
SLA bioprinting uses the same methods and machinery as traditional 3D SLA printing
but differs in the application of printed constructs. SLA printed constructs have application in
tissue engineering as extracorporeal or implantable acellular devices. Given the resins are cured
via UV light in most cases, this precludes the use of cells within the constructs themselves since
this curing method would kill inlaid cells. There are resins under development that use light in
the visible spectrum to cure, however the use of cells in these printers is unlikely because of the
nature of the printing process and the non-native properties of the resins [10]. Several researchers
have printed porous scaffolds upon which cells were seeded to create cell-laden constructs [11,12].
Additionally, researchers at BYU have developed a printer that can reach a resolution of 20 µm
in a channel width which approaches the inner diameter of a capillary bed [13]. Other researchers
have taken this same idea and made similar transparent devices that have cultured cells for several
days after washing [14].
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FDM bioprinters have become popular because of their similarity to traditional 3D extrusion printing and the gentle nature of cross-linking conditions that exist. As noted in the introduction, FDM bioprinters consist of a needle and syringe and the resolution of these printers is
dependent upon many factors including the step resolution of the motors, the needle size, and material properties. The step resolution of a printer will be defined by the manufacturer and depends
on the motors used and the gearing ratios for each axis. Generally, there is a trade off between step
resolution and print speed, meaning that very high-resolution printers take much longer to print.
The needle size is key in print resolution and of particular interest because in cell-laden constructs,
cells will have to survive the journey from the syringe, through the needle, and into the construct.
Studies have been done on the relationship between the needle diameter and the associated shearstress on the extruded ink and cells showing that a parameter optimization index (POI) may be
helpful in optimizing the needle size, print speed, and pressure [15]. This is an area where more
research needs to be done in order to verify, at the micron level, that the print designs going into
the printer are coming out of the printer and verify the printing parameters. This could be done by
extruding a polymer-like material that would be easier to measure and allow for the iteration and
optimization of printing parameters. Thus far, no method has been shown to characterize prints
beyond visual confirmation.
Several different FDM extrusion printers have been developed by researchers including the
ITOP system and an MIT printer as well as industry made printers including Allevi printers, Cellink
printers, and the Matrix printer. The ITOP system was developed at the Wake Forest Institute of
Regenerative Medicine and has been shown to print reliable anatomically-correct prints [16]. MIT
researchers have used another in-house printer to develop thick vascularized constructs with inlaid
cells which have proven successful [17]. The biomedical industry has produced several printers
with proven capabilities in printing a variety of materials. These printers span from $10,000 to
over $200,000 for industrial bioprinters and generally have a motor step size resolution of around
1 µm. However, it is becoming more popular to modify traditional 3D desktop printers to allow
for syringe extrusion and further adapt them for various cross-linking needs that may come about
depending on the bioink used.
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2.2

FlashForge Creator Pro and Duet WiFi Motherboard
The Tissue Engineering Lab at Brigham Young University had a Seraph Robotics Fab@Home

Dual Extruder which originally cost $4488 when it was purchased in 2016 shown in Figure 2.1.
This bioprinter worked on hardware and software that predated the 3D printing revolution which
standardized the types of stepper motors used in 3D printers as well as the code that these printers
and CNC machines run on, known as gcode. This meant that older software needed to be used in
conjunction with the printer that did not take advantage of the vast array of open-source software
that is available for newer 3D printers and with commercially available bioprinters. We determined
that it would be helpful to obtain a new bioprinter that would be much more user friendly and able
to achieve the resolution that would be required for the bioprinting applications we had in mind.

Figure 2.1: Seraph Robotics Fab@Home Dual Extruder

The search for a new bioprinter began by evaluating models from Allevi, then Biobot, and
CELLINK. These were priced within the $5k - $10k price range, which is reasonable in the small
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niche world of bioprinting. However, this was outside of the budget our lab had at the time and
we continued to look into other options. In the meantime, we were looking into bioinks to use in
conjuction with these bioprinters and were approached by a company out of Santa Clara, California. Advanced BioMatrix is a leading distributor of research-grade collagen with ties to Brigham
Young University and they were in the market to develop several bioink lines to sell to bioprinting
researchers. With their help we were able to make some connections to both Biobot to get a betatest version of their printer as well as T.J. Hinton at Carnegie Mellon University who was making
DYI bioprinters accessible to researchers. The Biobot beta-testing printer did not pan out, but the
connection with Carnegie Mellon University brought the possibility of making our own bioprinter
at a much cheaper price than what we could otherwise do. Subsequent discussions with T.J. Hinton
revealed that this would be a wonderful opportunity to get a high-resolution bioprinter into the lab
at the cheapest possible price. T.J. Hinton had developed a method to modify a printer popular
among 3D printing hobbyists for its ability to be easily modified. This printer, the FlashForge Creator Pro shown in Figure 2.2, cost around $1000 and has an X/Y axis resolution of 100 µm. T.J.
had the goal of selling the instructions to do the modification of this 3D printer into a bioprinter
for a profit, but the instructions were still being worked on. We agreed that he would share the
instructions with me in their current state if I would give him feedback on how to improve them
from a consumer standpoint. At that point it was time to buy the printer and start the modification.
As mentioned above, the FlashForge Creator Pro 3D printer was purchased for around
$1000 along with a Duet WiFi motherboard to work with the new extruder system that we would
be building for the bioprinter. The existing motherboard on the printer ran on its own firmware and
wasn’t able to be easily modified for the bioprinter; specifically, the motor steps/mm parameter was
going to be drastically different from the original printer as we were converting a traditional 3D
printing plastic-melting hot-end to a syringe based extrusion system. According to T.J.’s design,
the existing motherboard in the printer was to be switched out and all of the wiring moved over
onto the new Duet WiFi board. However, while the process of getting the parts for the printer
was happening, we found that the plastic 3D printer itself was very useful in the lab and we didn’t
want to lose that functionality if at all possible. We therefore decided to try and find a way to keep
both motherboards mounted and be able to switch between the two when we wanted to do either
plastic 3D printing or bioprinting. To solve this problem we came up with a solution involving a
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Figure 2.2: FlashForge Creator Pro 3D printer before modifications

large switch array that would switch the signal wires going to the motors from one board to the
other as well as the power supply to each board. As seen in Figure 2.3, this was done by using the
common wire as the input to each of the motors (of which there are four for each of the three axismotors) and then attaching the other two terminals to each of the outputs from the two different
boards. This had to be done while ensuring that the directionality was consistent between all of the
switches when they were mounted so that it was clear for the user as to which motherboard was in
play at any given time. The power supply was treated in a similar manner with the inlet coming
into the common terminal and the outlet being attached to the toggle switch which could switch
between and power the two boards separately. This switch also included a center-off function so
that it could be used as a power switch as well if necessary. The switch array example wiring is
seen in Figure 2.3B-C. With the wiring finished and tested we could now move to the programming
of the firmware for the new motherboard. Each of the axes stepper motors needed to have set in
the firmware the conversion between how many steps the motor takes and how that translated into
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Figure 2.3: FlashForge Creator Pro printer modifications A) SPDT wiring of switch array B) Example of the motherboard modifications C) Switchboard array to switch power supply and motor
signals from one board to the other.

a distance that the extruder or printing bed is moved. This is known as a steps/mm parameter and
for each of the axes that parameter didn’t change so it could be copied over from the firmware
of the original motherboard without difficulty. However, the extruder on the bioprinter is entirely
different from the 3D printer and this parameter had to be experimentally determined after the
extruder was constructed which will be discussed later. With these modifications the FlashForge
Creator Pro was finished with the electrical and mechanical modifications and the extruder itself
needed to be constructed.
Long after our modification of the FlashForge Creator Pro to our own in-house bioprinter,
I was contacted by Advanced BioMatrix, the company that originally connected us with T.J. Hinton, about beta-testing a printer for a start-up company they were working with. This company,
SE3D, had received an SBIR grant and were making cheaper bioprinters for use in research and
as educational tools in secondary educational settings. After talking with them we received one
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Figure 2.4: SE3D Matrix Bioprinter

of their bioprinters called the MatrixBioprinter, seen in Figure 2.4. It runs on the same Duet WiFi
motherboard we installed on the modified printer, but uses a slightly different type of extruder.
The original modified FlashForge bioprinter used a gearing system to transfer rotational motion
produced by the stepper motor to a linear motion to push a syringe up and down. This worked
fine, but had a lot of slack in the system and losses that created a lot of friction between the stepper
motor and the plunger. The SE3D extruder used a direct system where the stepper motor had a
linear actuator that extended through the motor itself and allowed for much finer control of the
syringe without all of the losses. This printer was used often in our research because it was smaller
and much easier to carry around versus the FlashForge bioprinter.

2.3

Paste Extruder Design and Construction
With the modification made to the FlashForge Creator Pro which maintained the plastic

3D printing abilities, it was time to turn to the construction of the extruder system. The system
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used on the FlashForge bioprinter was designed by T.J. Hinton and represents the bulk of his
contribution to the conversion. The hot-end plastic extruder on the original FlashForge Creator
Pro was completely replaced by a 3D printed version which allowed for a variety of sizes of glass
syringes to be attached and held firmly in place while the plunger was moved by the extruder motor,
resulting in a predicable extrusion from the end of the syringe. As partially seen in Figure 2.5, the
extruder consists of a rail carriage able to fit three extruders, and the extruder-motor component
itself. The extruder-motor component contained a main body to hold the bulk of the syringe, a
gearing system, motor mounting attachment, and syringe securement mechanism. All of these
parts were 3D printed in PLA, and attached together with hex screws and nuts.
This particular design was developed early on by T.J. Hinton and his team at Carnegie
Mellon, and there are flaws that we tried to address while using it. Carnegie Mellon is currently
working on a newer version and have changed the design to include a tube attaching the extruder
syringe end and the needle tip in a sort of ”Bowden-style” design. We have not tried this version in
the lab, but slightly modified the original extruder to help its usability. The original extruder was
designed to use glass syringes but many times a plastic syringe was easier to use over a glass one.
We designed a small plastic insert that would allow plastic syringes to be used which made it more
practical for lab use. However, the extruder still had a lot of slack and play in the gearing system
and plunger versus the direct drive system seen on the SE3D extruder.

2.4

Summary
With the end goal of tissue engineering being the construction of human tissue, the process

of additive manufacturing seems to be one of most broadly used methods to get there. Bioprinting
uses additive manufacturing to lay down biologically compatible materials, possibly laden with
cells, to build a tissue-like construct that can then mature and be implanted. With the help of
Advanced Biomatrix, SE3D, and T.J. Hinton from Carnegie Mellon University, we were able to
get two bioprinters into the lab. The first printer was modified from a FlashForge Creator Pro 3D
printer with a 3D printed extruder. During this process we made additional modifications along
the way including a switch array that allows the printer to have dual functionality as a 3D printer
and a bioprinter. The extruder was printed using the plastic 3D printing function on the printer and
allowed the plastic hot-end of the extruder to be replaced by a paste-extruder which used a glass
13

Figure 2.5: 3D printed extruder mounted to the modified FlashForge Creator Pro bioprinter. Has
spots for three extruders.

syringe. After the completion of the printer conversion we were also able to obtain a beta-test
version of SE3D’s Matrix Bioprinter which was used in the lab extensively. The extruder on the
SE3D printer had features including a direct-drive system which could more accurately control
the syringe plunger versus the converted FlashForge printer. This part of the project concluded
with two working bioprinters in the lab as well as a plastic 3D printer that can perform the dual
functionality of the FlashForge bioprinter.
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CHAPTER 3.

3.1
3.1.1

BIOINK FORMULATION AND TISSUEBOX DESIGN

Background
Material Characteristics
Printing materials become important for FDM and SLA style printers with complex con-

straints such as biocompatibility and cross-linking methods. FDM material selection and development is currently a popular area of publication, and many articles have appeared in the last
year addressing a variety of materials. Many researchers have performed detailed reviews into
available materials as well as potential needs for future material development in FDM bioprinting. Researchers in Germany recently discussed the bioprinting of structural proteins and their
eventual use in the formation of an extracellular matrix scaffold [9]. In the area of bioprinting
hydrogels specifically, many researchers are looking into using hydrogel blends such as collagenalginate, collagen-methacrylated gelatin, alginate-polyvinyl alcohol, gelatin-alginate, and others,
which have varying levels of success when it comes to printability and biocompatibility [18–22].
Most popular currently is a collagen bioink sold by Advanced BioMatrix as Lifeink 200, a pure
Type 1 Collagen bioink (https://www.advancedbiomatrix.com/bioinks-for-3d-bioprinting/lifeink200-concentrated-type-i-collagen-5202-1ea/). This bioink is, however, expensive for labs with
limited funding and not customizable in terms of the collagen concentration. Some research has
been done in deriving a collagen-based bioink from the extra-cellular matrix of decellularized organs (dECM) which holds promise for a cheaper but still native-like bioink [23,24]. There remains,
however, a need to more fully develop these decellularized bioinks. A practical approach to making and tailoring them in the lab would provide a collagen bioink source for researchers to use for
their own needs.
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3.1.2

Printing Substrates
Paste-extruding FDM style bioprinters need to print in a support substrate to suspend

bioinks prior to cross-linking. This printing substrate needs to be viscous enough to hold the
bioink in suspension but thin enough to allow for needle movement and not affect the surrounding
deposited ink. Researchers from Carnegie Mellon University have developed two different methods of doing this, using a carbomer polymer gel and a blended gelatin bath. The carbomer bath
has been shown to be useful in printing poly-dimethyl siloxane, a silicone polymer, and other nonbiological material [3]. Another method referred to as freeform reversible embedded suspension
of hydrogels (FRESH) is used with collagen and other more delicate and thermally cross-linked
bioinks [4]. These two printing substrates cover most needs related to bioprinting, though there are
a number of other possible products that have similar properties that could work as substitutes.
Some printing methods, known as scaffold-free, don’t require the use of a printing substrate
because either the ink used is sturdy and stable enough to support itself layer upon layer, or the
print method allows for other means of support. One method shown by researchers used cell-laden
cylindrical agarose rods stacked up into desired designs to assemble a simple vasculature [25].
Thyroid organoids were developed in another study where a collagen gel held cellular spheroids
which gradually grew together to form functional thyroid tissue [26]. UV cross-linkable hydrogel
inks have also been shown to be extruded without a support substrate depending on when in the
printing process curing occurs [27]. In developing an artificial urethra, researchers have shown that
a cell-laden blend of PCL/PLCL is structurally sound enough to be printed on its own and provides
a framework upon which urothelial and smooth muscle cells can grow and mature [28]. These
scaffold-free printing methods provide promise, however they are difficult to use with biologically
native materials currently in use.

3.2

Freeform Reversible Embedded Suspension of Hydrogels - FRESH
During bioprinting, paste-like extrusions are held within a syringe and dispensed through

a needle to await cross-linking where they become more solid-like. Maintaining the printed shape
while the cross-linking happens, by whatever mechanism that may be, is one of the unique problems of bioprinting. An excellent way to overcome this problem is to print into a substrate with a
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tunable viscosity such that it will hold the printed bioink in place until it is cross-linked and then
release it by dropping the viscosity. Normal plastic 3D printers print in air as a substrate which
works well for the thermal cross-linking that takes place, but air is not practical for bioprinting.
Researchers at Carnegie Mellon University developed a method call the Freeform Reversible Embedded Suspension of Hydrogels, called the FRESH printing method for short, which takes gelatin
which has been gelled and cuts it into small particles which acts like a viscous slurry similar to the
consistency of hair gel as seen in Figure 3.1. This gelatin slurry is thick enough to hold bioinks
in place while they are printed and has the unique property of being shear-thinning. This is advantageous in bioprinting because the needle is traveling through this printing substrate during the
printing process and if the gel is shear-thinning then the momentum transfer of the needle as it
is moving won’t disturb previously extruded materials and ruin the resolution of the print. The
FRESH gelatin slurry can then be heated after the bioink is cross-linked and the gelatin will melt,
greatly reducing its viscosity and the print can be released from the printing substrate. The melting occurs under 37 °C which is physiological temperature and the temperature at which cells
are incubated, so the releasing procedure doesn’t harm inlaid cells. This melting property, the
shear-thinning properties, and the inherent biological compatibility of gelatin combine to make the
FRESH printing method very popular and ideal for thermally cross-linking bioinks like collagen
that will be discussed later.

3.2.1

Protocol
This method of printing was laid out in a journal article along with the protocol to make

it [4]. When we first came across the paper and protocol it was apparent that this was the method
that would work well for our purposes. Initial tests showed that making the FRESH was quite
difficult and not a simple procedure to master. During this process I was able to visit Advanced
BioMatrix in San Diego, California, the company that makes the Lifeink line of bioinks, to see their
plant and discuss a possible collaboration and SBIR grant. While there I was shown how they made
the FRESH gelatin-slurry and saw a few things we could improve upon in our protocol and were
able to obtain a copy of their protocol in the process. The protocol that follows is a compilation of
the original protocol published by Carnegie Mellon University, the protocol provided by Advanced
Biomatrix, and our own modifications to make the gelatin-slurry with our equipment.
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Figure 3.1: Gelatin slurry used in Freeform Reversible Embedded Suspension of Hydrogels
(FRESH) printing

FRESH Protocol
Accessories:
1. Gelatin (Type A 150-300 Bloom)
2. Distilled water
3. Stirring hot plate
4. Spatula
5. Blender with individual serving cup attachment
6. Glass beaker
Protocol: Part 1: Preparing the Gelatin
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1. Introduce 250 mL of distilled water and 10 g of gelatin to 500mL glass beaker.
2. Mix solution on a hot plate with a fast stir bar, with hot plate at 150 °C until gelatin dissolves.
Fully dissolved solution should be transparent. With the stir bar going fast, little bubbles
will exist in the solution while on the hot plate. These will disappear, and the solution will
become transparent shortly after removing the beaker from the hot plate.
3. Pour solution into individual serving cup from the blender. Wash beaker and stir bar.
4. Store in refrigerator until set (10 hours is plenty).
Part 2: Blending gelatin
*Having cold water will help prevent gelatin from melting into solution when doing multiple washes.
1. Remove mason jar from the refrigerator and fill the remaining space halfway with cold water.
2. Take a spatula and separate the gelatin from the walls of the jar to introduce water between
the sides (not the bottom) of the gelatin puck and the container (Ensure full separation of gel
from the sides, or the gelatin will not blend correctly).
3. Fill the jar in the sink with additional cold water. Get a big meniscus over the lid.
4. With the jar still in the sink, carefully screw the blender blade lid on the jar. Water will pour
out, but you should have avoided introducing much air into the jar. Only a tiny air bubble
should be present now. If a substantial air bubble exists more washings will be required later:
Take lid off, fill with more water, and repeat.
5. Place the jar (with the attached lid/blade) into a -20 °C freezer for 2-5 minutes. This will
help to prevent the gelatin from melting during blending.
6. Blend mixture by holding down the jar for 20 seconds. Make sure that gelatin puck drops
within the first 5 seconds on the first blend.
7. Place the blender in the freezer for approximately 1 minute.
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8. Repeat steps 6. and 7. six more times, so the total blending time is 140 s.
*Avoid adding unnecessary heat to the system by not holding the jar with your entire hand.
*If blender overheats, the gelatin will turn into a big clump. Keep it cold.
*After blending, the solution should be pipettable and not overly viscous/gelatinous.
*Keep all materials cold (refrigerated) from this point forward as warming the solution will
cause the gelatin particles to melt.
Part 3: Centrifugation
1. Pipette 45 mL of the gelatin slurry into 50 mL centrifuge tubes.
2. Centrifuge at 3,800G for 2 minutes at 4 °C.
After centrifugation, the tube should contain a compacted pellet of gelatin slurry with a
somewhat cloudy supernatant, and a white foamy top layer. This white foam raft is the
soluble gelatin. (Ideally, the white foamy layer is minimal or non-existent.)
3. Pour off the supernatant and raft (if there). If there was no foamy raft, you are done; store
the FRESH slurry in an airtight container. If there was a foamy raft:
(a) Refill tube with cold water.
(b) Shake vigorously or vortex to re-suspend all the slurry. Shaking vigorously helps introduce air bubbles, which help in removing soluble gelatin. It is fully suspended when
there is no more slurry at the bottom of the tube.
(c) Repeat steps 2 and 3 until no to little foam is observed at the top of the supernatant.
This indicates that most of the soluble gelatin has been removed.
(d) After the last centrifuge, the slurry is ready to use. If storing, refill the tube with cold
water and mix again. Store the FRESH slurry in a refrigerated airtight container.
This protocol is different from others in the blending method. The original protocols took
the gelatin puck and did the entire blending in a single step. This took up to 90 seconds of blend
time and had the risk of overheating and destroying the blender itself. At times the blender itself
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was put in the freezer before and during the blending of the gelatin to try to avoid this issue when
doing the blending in a single step. After some experimentation, we found that a series of shorter
blending times gave us the same result as a single long blend without the risk of overheating and
ruining our blender.
This method of making the FRESH worked very well for us and produced very consistent
results that we could use as a printing substrate. Though our work never progressed to the stage
to where we printed with live cells, it was still necessary to find a way to sterilize the FRESH in
preparation for that. In general, sterilization techniques include chemical, radiation, and thermal.
After the gelatin slurry was made, it clearly could not be sterilized thermally in an autoclave as it
would destroy the gelled structure of the particles that had been created. Chemical sterilization was
attempted using 70% ethanol, but an esterification reaction resulted in a gelling of the slurry which
destroyed the micro-particles that were formed during the blending process. After a discussion
with T.J. Hinton at Carnegie Mellon University, we decided to try and sterilize the FRESH from
the beginning of the process and sterilized the powdered gelatin via UV radiation from a 30 minute
exposure to the UV sterilizing light in our biosafety cabinet, as a part of it’s normal sterilization
procedure. Then sterile water and other sterile materials were used throughout the rest of the
process of making the slurry. This proved to be difficult, with lots of places to make an easy error,
but in the end we were able to make sterile FRESH using this method.

3.3

Alginate
The first material that we used as a bioink was alginate, a polysaccharide derived from

brown seaweed. Alginate is commercially used as a thickening agent in food and drinks and
is the gel-like shell of popping boba and fake caviar. In tissue engineering research, alginate
is used as a hydrogel for cell encapsulation, wound healing, and drug delivery. It has excellent
biocompatibility, a very low toxicity when interacting with cells and can be cross-linked gently for
cell encapsulation [29].
Alginate is generally found as a salt in coordination with sodium and is bought as a powder.
This powder is dissolved in water while stirring to achieve different concentrations. The alginate
powder generally has a hard time forming a homogenous mixture and requires continuous stirring
to make a good gel. The higher the concentration of alginate in the water the more difficult the
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mixing becomes. Common concentrations are around 0.1% - 5% by weight. Alginates will have a
wide variety of viscosities based on their concentration and do show some shear-thinning behavior.
At low shear (0.01 s -1 ) the viscosities can vary from 1 - 1000 Pa s-1 for various concentrations and
molecular weight [30]. Because bioprinting uses a needle, usually around 100 - 500 µm in inner
diameter, this viscosity and the extent of the shear-thinning behavior strongly impact the use of
alginate in bioprinting. Alginate gels that are too thick simply can’t be extruded through the needles
with the pressure generated by the stepper motor when pushing on the plunger. The cross-linking
method also impacts how alginate is used in bioprinting. Generally, sodium alginate is cross-linked
by calcium ions which ionically cross-link alginate strands and form the hydrogel. This would be
under the category of chemical cross-linking and and presents a unique challenge when bioprinting
is popularly done in a printing substrate such as FRESH as previously discussed. The challenge
is that calcium needs to be introduced into a gelatin slurry substrate after the alginate has been
extruded. It has been found that mixing a low concentration of calcium chloride into the printing
substrate will allow the alginate to be slowly cross-linked as it is extruded but allow time for
parallel extrusions to gel together and not as individual strands as demonstrated in Reference [4].
Alginate is often used as a bioink on its own or as a component of a complex bioink.
Alginate has been used as a general purpose bioink mixed with gelatin [31], in 3D cell culture [32]
[30], and in bone tissue engineering in conjunction with polyvinyl alcohol and hydroxyapatite [33].
Alginate was used as the first real bioink in our research and was used extensively for several
months. Generally a 2% alginate concentration was used in the bioink and an 11mM CaCl2 was
incorporated in the FRESH printing substrate. This created an alginate shell that would slowly
cross-link in the FRESH solution, but we found that it was necessary to add more calcium to the
alginate to sufficiently cross-link it so that it could be handled. This was done by sprinkling CaCl2
pellets on the top of the container holding the FRESH and printed alginate. There was enough
water in the FRESH slurry that the CaCl2 was quickly dissolved and helped to further cross-link
the alginate. In initial investigations, we were simply trying to find the practical limits of resolution
on the alginate bioink in a FRESH substrate. A 16-gauge needle was used to start which gives a
large inner diameter of 1.19 mm. This clearly decreases the resolution of a particular print because
the larger cross-section of the extrusion from the needle means you have thicker layers and overall
fewer extrusion passes to create the structure. Figure 3.2 shows an example of what was printed
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Figure 3.2: Bioprinted alginate showing a bifurcated channel. Resolution is poor and the channels
were not as open as originally printed becuase of the swelling nature of the cross linked hydrogel.

using this thicker gauge needle. The resolution was poor and it was difficult to achieve consistent
results. One problem that became apparent was the fact that alginate swells as it is cross-linked,
and that swelling ratio changes depending on the alginate concentration. This is one of the reasons
that we started to look into other bioinks or blends that would provide properites that could be
tuned to our needs.

3.4

Decellularized Collagen-Based Bioink
Collagens are the most abundant protein in the body and are a major structural component

of all tissues. Tissue consists generally of cells, the functional unit in biology, and the extracellular
matrix (ECM), which exists between the cells and provides structural and nutritional support. The
major protein in the ECM is collagen, a structural protein made from a repeating three amino acid
sequence consisting primarily of glycine and proline residues in a triple helix structure. Collagen
can be derived and purified from many sources including bovine, rat, porcine, and human. Purified and dissolved collagen can have the rheology modified depending on the concentration and
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temperature of the collagen, as well as the type [34]. Uncross-linked collagen can be cross-linked
back to a native-like state by thermal and chemical means depending on the application [35]. Traditionally, a thermal mechanism is used which only requires the temperature to be raised to 37 °C,
the temperature at which cells are incubated, which makes thermal cross-linking very handy.
Collagen is used in tissue engineering research as 3D porous constructs, gels, wound healing constructs, and many other applications. Collagen, such as the types sold by Advanced BioMatrix (https://www.advancedbiomatrix.com), can be used in similar applications where Matrigel
would be used in making gels and encapulating cells. Recently there has been a huge increase
in the use of collagen in bioprinting applications as this manufacturing method has taken off in the
tissue engineering world. To only list a few, researchers around the world are using collagen in the
following bioprinting applications.
• Bioprinting a cornea replacement for implantation [36]
• Developing a blood vessel network for tissue generation [37]
• Tissue engineering applications for artificial blood vessels [38]
• Bioprinting a tracheal segment in a rabbit study [39]
• Bioprinting a hybrid cardiac patch for myocardial repairs [40]
• Heart valve replacements bioprinted from collagen and elastin [41]
• Recreating a liver microenvironment with a collagen hyaluronan bioink [42]
All of these examples use collagen and several use a specific bioink developed by Advanced
BioMatrix called Lifeink 200. This is a concentrated Type 1 collagen that has been modified to
be stable at room temperature and not begin to cross-link until 37 °C. This is advantageous over
other collagens that will start to cross-link at room temperature even though they don’t fully crosslink until they are placed in an incubator at 37 °C. With Lifeink 200, bioprinters don’t need to be
kept in a low-temperature environment while printing: it can simply be done at room temperature.
One downside to Lifeink 200 is the cost at $230/5 mL. Although this is not an exorbitant amount,
for labs with little funding this cost adds up quickly, particularly if you are printing anything
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of substance around the 1 mL range. Another problem is that you are not able to specify the
collagen concentration. When printing straight collagen this may not be a concern as the provided
concentration works well for many applications, but when blending different materials together
to form a new bioink, changing the collagen concentration can be very helpful. To address these
concerns and alleviate the cost of the bioink, we decided to make our own bioink as other labs have
done which would provide us a consistent supply of our own custom made bioink.
The purification of collagen required expertise and equipment that we did not possess, we
therefore went with a slightly more unconventional bioink that we did have the ability to manufacture. We decided to go with a bioink slightly different from Lifeink 200 in the form of a decellularized ECM (dECM) bioink. In its nature, a dECM bioink is composed of mainly collagen, as the
ECM itself is mostly collagen, with other additives that were a part of the ECM in the particular
region where the tissue was harvested. This might include hyaluronic acid, glycosaminoglycans
(GAGs), and other protein, fat, and sugar molecules in the ECM. Our lab had unique access to
decellularized tissue from the work of Dr. Alonzo Cook and his former PhD student Dr. Nima
Momtahan. Weekly in the lab, porcine hearts harvested locally were decellularized by a process
outlined and optimized here at Brigham Young University [43]. About half of the decellularized tissue would be used in a heart study seeding cells onto thin slices of the tissue, the rest was normally
discarded. This residual tissue was used as the source for our dECM bioink following protocols
from several other labs. Stephen Badylak’s lab at the University of Pittsburgh was a pioneer in the
area of decellularized tissues and his research heavily influenced the development of the optimized
decellularization process done here at BYU. His research has taken decellularized tissue in several
forms and applies them directly in surgery and in the manufacturing of a hydrogel [24, 44, 45].
Karen Christman, a professor at the University of California, San Diego has done a lot of research
into decellularized organs and turning them into a hydrogel. The protocol to dissolve decellularized tissue discussed throughout several articles from her lab was very helpful in getting us started
on our own protocol as well as other research reported on from her lab [46–51]. Most helpful in
our efforts to make a dECM bioink was the work by Dr. Dong-Wo Cho at Pohang Universtiy of
Science and Technology in South Korea. His work was most directly linked to our own as his goal
was to 3D bioprint with a dECM. His other work was closely associated involving cross-linking
techniques and developing vascularized tissue [23, 52–54]. The Cho lab’s protocol dissolves the
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ECM in a way very similar to the Christman lab. However, the application of the printed bioink
in the Cho lab involved an extra support ink which we did not want in our bioprinting process, so
our final protocol did not match exactly with the Cho lab. Our final protocol to develop a dECM
bioink is an agglomeration of the research done by these labs as well as a lot of trial and error done
in the lab here at BYU.
The protocol starts with the decellularization of the tissue which we will cover briefly. The
process of decellularization generally consists of breaking down the cell membranes while keeping
the ECM intact. Detergents and enzymes are used in conjunction with hypertonic and hypotonic
solutions that breakdown and then cyclically shrink and swell the cell. This combination breaks
down the cells and washes them out while keeping the ECM intact. Various researchers have
published different protocols on decellularizing tissues including muscle and bladder [43, 55, 56].
In our lab, porcine hearts are harvested locally, cleaned, and frozen until needed for the weekly
decellularization. The hearts are thawed and then hooked up to a peristaltic pump and various
solutions are pumped through the heart as described above. This process takes the cells out of the
tissue and leaves the ECM, which is needed in the dECM bioink. After the tissue has gone through
the decellularization process it needs to be dissolved and broken down. Specifically, the collagen
needs to be broken down to an un-cross-linked state where it can be cross-linked again by a thermal
treatment. To do this we started by following the protocols discussed above from the Christensen
and Cho lab along with several other labs which did similar processes [57–59].

Protocol
1. Blend decellularized heart tissue
This is done in a normal blender and allows the dissolution of the tissue to happen faster
when the acid and pepsin are added. Could also be a method in larger scale productions
where the tissue could be homogenized with other batches to eliminate variety among the
source tissue.
2. Filter blended tissue through cheese cloth
The blended tissue was filtered through a simple cheese cloth so that as much water as possible could be eliminated from the tissue. This is so that a consistent collagen concentration
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could be made each time and the concentration could be made more specifically to what we
wanted. After the dissolution that happens next it is very hard to concentrate the collagen
further by eliminating water, but it is simple to add water and dilute it down, thus we tried to
get the highest concentration possible initially.
3. Combine tissue with 0.5 M acetic acid and 50 mg pepsin/10 mL blended tissue.
The dissolution of the ECM is done partially by the acid, but mostly by the pepsin enzyme.
Pepsin is uniquely activated at low pH and thus works well in this environment. The 0.5
M acetic acid concentration is achieved by adding in stock acetic acid directly to the tissue
mixture that has been drained. This does not initially create a 0.5 M solution becuase there
is not enough water to dilute the acid to that concentration, however, after the enzyme does
its work more water is released from the ECM and the final volume of water does bring the
acetic acid concentration to 0.5 M. This was determined to be the most effective method
to keep the collagen concentration high in the bioink and not dilute out the collagen. The
optimized mixture added 0.278 mL of glacial acetic acid to 10 mL blended tissue, which
after mixing provided the water necessary to achieve the 0.5 M acid concentration.
4. Mix for 48 hours
The mixing was done in a 50 mL conical vial with an improvised mixing system similar to
the set up of a continuously stirred tank reactor. This consisted of an externally mounted
electric motor with a power supply attached to a mixing shaft that stirred the mixture continuously for the duration. This was chosen over a magnetic stir bar becuase the mixture was
too viscous for the stir bar to reliably mix the entire volume.
5. Filter dissolved mixture through cheese cloth
The mixture was filtered through a second clean cheese cloth to pull out any undissolved
tissue or other foreign particles that may have been present in the original tissue. This needed
to be done carefully however as there was insoluble collagen in the mixture that is easily
separated out but is vital to the successful cross-linking of the final bioink.
6. Add pH indicator and 1mL 10x PBS
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The pH indicator is very helpful in the next step where the pH is changed to a physiological
pH of 7. The PBS is added to return the salt mixture back to physiological conditions after
the original washing of the ECM that happened during the decellularization process. We
later found out that this step may not be needed due to the breakdown of the ECM and subsequent release of ions which raises the osmolarity higher than initially expected. However,
it is very difficult to ascertain the exact osmolarity of the dissolved collagen mixture to know
how much PBS needs to be added and more research needs to be done in this area to find
a consistent way to achieve an osmolarity of 300 mOs. The addition of the PBS or water
here is the place where the solution could be diluted down for different collagen concentrations, however in most of our work we used the highest collagen concentration possible to
maximize the strength of the post-cross-linked prints.
7. Add 10 M NaOH to change pH to physiological conditions
To not dilute the bioink, a high concentration strong base was chosen to change the pH. This
was very effective, but troublesome because very small volumes made dramatic changes in
the pH, particularly when getting near the equivalence point. Additionally, the dECM bioink
will not cross-link at low pH, but when it is raised to above a pH of 6 the collagen will crosslink at room temperature. This means that the pH change needs to be done in refrigerated
conditions of below 4 °C to ensure the collagen will not cross-link when the pH is changed.
Practically, this was accomplished with a tub of ice water that the dECM bioink could sit in
while the pH was changed dropwise with the base.
8. Centrifuge bioink in refrigerated conditions at 3000 rpm for 5 min
Given the pH change made it possible for the collagen to cross-link at temperature above 4
°C, all further processing had to be refrigerated. The centrifuge step pulls out bubbles that
accumulated during the processing of the bioink, the initial mixing and the pH adjustment,
which can make the bioink less predictably compressible and require more adjusting of the
printing parameters when using in the bioprinters.
This protocol, as mentioned above pulls heavily from the contributions of the Christman
and Cho labs with slight differences. First would be the method of decellularization of the tissue.
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Figure 3.3: Process of making the dECM. A) Decellularized porcine heart B) Powderized and
lyophilized decellularized tissue C) Mixing of bioink during digestion process by acid and enzymes
D) Initial addition of pH indicator showing acidic bioink after mixing E) Finished bioink with pH
changed to neutral.

The process our lab uses keeps the vasculature intact for later seeding of cells in other studies as
shown in Ref [43]. This vascular structure is not required in our use of the tissue as the base for a
bioink and is much more complex than would be necessary if the decellularized tissue were to only
be used for a bioink. A simpler process is used by the Christman and Cho labs. Other differences
include the use of the pH indicator and the purification process. Our use of a pH indicator, phenol
red, made changing the pH much more practical, especially when the bioink needed to be kept cold
to keep the collagen from cross-linking. The purification steps we took, including the straining and
centrifugation, are unique and help to make the bioink process more repeatable and predicable.
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Figure 3.4: Bioprinted examples of dECM Bioink A) LifeCube with single inlet/out B-C) High
resolution nose from side and below views D) Cross linked dECM bioink in air.

The next step in the formation of a working bioink was to sterilize the material and determine how cells act and grow in the bioink. We tried many methods of sterilizing the bioink,
but no method worked well to preserve the structure of the uncross-linked collagen. Autoclaving
the bioink denatures the collagen protein and does not allow it to cross-link later on. Radiation
and chemical sterilization techniques that were tried proved to not be practical or not achieve the
sterilization required. The method that ultimately worked was sterilizing the decellularized tissue
initially before the tissue was dissolved and then keeping subsequent steps sterile.

3.5

3D Cell Culture Model and TissueBox Design
A true 3D cell culture, with cells placed in the right spots and a vascular system attached

to provide support to the cells, is essentially no different from a native biologically derived tissue
found in any animal or human. The real challenge comes in recreating that 3D cell culture environment, and successfully doing that may still be decades away. However, if we could recreate the
3D cellular environment, then a 3D cell culture made in the lab may be able to replace an animal
model for drug testing. If it were good enough, it may even be able to stand in the place of human
testing, if we can really recreate that environment. On the way to that goal of recreating the 3D cellular environment, one of the first benchmarks will be to create a vascularized 3D cell culture. The
current holdup in 3D cell culture is essentially a plumbing problem. It is not possible to provide
the flow of cell culture media necessary for cell survival to all of the cells in a bulk environment.
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In native tissues, the standard for a diffusable distance where nutrients and waste can travel from a
capillary to the farthest cell is about 200 µm. This distance will likely increase in an immature cell
culture with essentially no developed ECM, but cells will likely need to be within at least 500 µm
of a cell media supply to survive and mature. This is why a plumbing system, or vascular network,
is needed for 3D cell culture to become a reality. The best 3D cell culture we have now is in the
form of cell spheroids which are very limited in size because of the diffusion problems that are
created and the lack of nutrient/waste exchange for the cells in the center of the sphere. What we
need to make 3D cell culture a reality is a vascular network, for media to flow to cells throughout
the bulk of the cell culture and allow them to proliferate and operate in 3D. A good review of the
current state of vascular tissue engineering, and what steps still need to be taken, was done by Gui
and Niklason [60].
A study from the Rensselaer Polytechnic Institute in 2014 showed that two parallel 3D
printed channels within a hydrogel with various cells and growth factors were able to form a
capillary network between the two channels [37]. This study showed that it is not necessary to
print a capillary network, which can reach a diameter as small as 10 µm, but a capillary network
can be grown within a hydrogel and attach to larger channels that can be 3D printed. Similar studies
show that angiogenesis, the formation of new blood vessels, can be accomplished with various cell
types and growth factors in different hydrogels including fibrin [61, 62]. Combining these ideas,
we developed a bioprinted 3D cell culture design with open channels for the flow of cell media
and parallel channels arranged such that angiogenesis could establish a capillary bed between the
inlaid channels. The first version of this design was termed the LifeCube as seen in Figure 3.5
A,B. It featured a single inlet/outlet to be attached to a peristaltic pump and a series of branches in
3-dimensions that formed the parallel channels where the angiogenesis could occur. It was printed
in collagen, but was not tested with cells because of the sterilization challenges discussed earlier.
This version was submitted with the bioink company Advanced BioMatrix as the basis for an SBIR
grant using their bionks and our biopriting and cell culture capabilities. The SBIR was ultimately
not funded, but the design continued to be developed as we developed our own bioink and our
bioprinting expertise matured.
A later version of this concept was named the TissueBox shown in Figure 3.5 C,D The
TissueBox has yet to be thoroughly tested, but remains as the culmination of all of our work and
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experience in bioinks and bioprinting. The TissueBox is the best guess we currently have as to
what a 3D cell culture may look like when approached from a 3D bioprinting point of view. It is a
unit cell featuring a single open channel that can be stacked horizontally and vertically to achieve
any thickness or shape desired. This unit cell is created from a structurally supportive alginate
cage with a dECM bionk as the primary bioink and cell carrier. This design utilizes the structural
advantages of alginate gels, discussed earlier, which can have a variety of stiffnesses depending on
the alginate concentration and the native cell-friendly nature of the dECM bioink with collagen.
The TissueBox would be printed in a FRESH support slurry with two different bioinks, the strucural alginate hydrogel, and the cell-laden dECM bioink. After printing, the construct would be
placed in an incubator where the bioinks would solidify and the FRESH liquify and the construct
could be attached to a peristaltic pump for cell media perfusion by a single inlet/outlet design with
branches or attachment to a specially designed microfluidic device. If a system like this could
be reliably made in the lab with a bioprinted vascular network and an induced capillary bed via
angiogenesis then this would be the first real method of achieving a true 3D cell culture. Once this
was proven to allow for cell proliferation and maturation, a variety of cell types could be included
in the cell-laden dECM bioink for testing in this environment. Pancreatic beta cells could be tested
and see how they respond to glucose levels in the perfusion media, or cancer cells could be allowed
to mature in 3D and then treated with various drugs. The development of a true 3D cell culture
method would revolutionize the way that we currently use cell culture and will be the next step in
the progression towards an artificial tissue.

3.6

Conceptual Design of a Better Bioink
There may not be such a thing as the perfect bioink. It may be best to customize the bioink

for each application you are using, for instance, if the goal would be to make artificial heart tissue
then it may be advantageous to use decellularized heart tissue as the basis for the bioink. Or
perhaps it would work best to use a certain blend of collagen for muscle tissue regeneration. There
are some overarching principles that are starting to be established that every bioink will need to be
based around.
The first principle is that the bioink should be almost entirely biodegradeable by the cells
themselves. The goal is to have the cells completely remodel the scaffold that was printed and
32

Figure 3.5: LifeCube and Tissue Box designs. A-B) Lifecube designs featuring a single inlet/outlet
and a branched parallel channel network C-D) TissueBox design, individual unit with scaffold
structure and multiple units in parallel.

replace nearly all of the material there with proteins and other ECM components. This means that
the bioink either needs to be recognized and incorporated by the cells into their ECM, or used as
a nutrient source that will be used up as the cells grow and proliferate. We tried to address this
principle by mixing alginate and our dECM collagen bioink together. The alginate is partially
biodegradeable in its ionically cross-linked form, but the MW of the original strands and the lack
of the enzyme alginase in mammals creates problems in the total elimination of alginate [29].
Alginate is not a total solution by any means to the first principle, but may play a part in a totally
biodegradable bioink.
The second principle is more obvious, that the construct to be implanted needs to be durable
enough to withstand the stresses of surgery and suturing as well as the harsh environment it is
implanted into. It is currently unclear as to when that implantation process should occur, or where
the artificial tissue should be allowed to mature, in vivo or in vitro, but wherever that happens to
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be, the printed construct needs to be durable enough at all points on the path to endure the process.
This means that more than likely a structural element will need to be included in the bioink or
printed as a second bioink to help maintain the structure of the print as it matures and the cells
remodel the structure. As with the first principle, alginate may work well for this purpose because
of the strong structural role it can play when it is used in high enough concentrations. However, the
cross-linked alginate, even at the highest concentrations, is not an objectively very strong material,
only in regards to other hydrogels. In conjunction with the first principle, this structural material
will need to be biodegradeable as well as provide structural support. There are several polymers
that may work well for this, but those would also need to be bioprinted and cross-linked to work in
this kind of process. Fibrin may be a possible material choice which has already been 3D printed
many times and used as a biodegradeable hydrogel in cell culture [?, 63, 64].
The third principle is similar to the second, that the cross-linked bioink needs to be soft
and porous enough to allow the cells to be unconstrained in their proliferation. In current 2D cell
culture, there is no scaffold for the cells to fill, there is only a roughened up surface for the cells to
attach to as they proliferate, but they are proliferating in essentially a water bath with no obvious
physical hindrances to their growth. When you add a 3D scaffold to the mix, things get more
complex because you are adding a third dimension for the cells to proliferate into and attachment
surfaces beyond the 2D plane, but at the same time you add obstacles in the way of the cells that
may deny free-floating cells the path to attach to surfaces in that third dimension. However, this
does not seem to be an issue for commercially available skin scaffolds sold by Acell (acell.com)
which cover various dermal wounds and provides a and cell-free scaffold that decreases healing
time and scar formation. More research needs to be done likely with cells once the demands of
principles one and two are met to see how the cells will migrate through the chosen material.
These three necessary principles highlight why a good bioink is so hard to develop. The
ideal cell-carrying bioink will need to be porous enough to allow for cell proliferation, strong
enough to be sutured to, and biodegradable such that the cells can remodel the scaffold structure.
All of these principles have not yet been optimized in any combination of bioinks that we are aware
of, but these principles can help to guide us towards certain material choices.
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CHAPTER 4.
ANALYSIS

4.1
4.1.1

BIOPRINTER PARAMETER OPTIMIZATION AND RESOLUTION

Background
Feedback Methods
One of the most difficult parts of additive/subtractive manufacturing is resolution and toler-

ance analysis to determine how the finished product matches the designed model. When machining
aluminum for instance using a computer numerical control (CNC) machine, the finished part needs
to be measured and compared to the original design to ensure it falls within specified tolerances
for that part. For a metal part that may be a time consuming process, but not difficult. The part
is physically measured either electronically or manually and evaluated or the part is compared to
a specially designed and machined tolerance part which fits on/in the newly machined part and is
able to quickly identify if the part is within specification. This method can be used to evaluate most
traditionally 3D printed parts as well because they are generally hard plastic and can withstand that
kind of evaluation. Additionally, in a 3D printing system you have instant visual feedback on how
the process is going and can change parameters on-the-fly to improve the quality of the print or the
print can be evaluated post-print and parameters changed to ensure that the optimal resolution is
obtained. However, in bioprinting, this method of resolution analysis and parameter optimization
cannot be done for several reasons. First, the final printed constructs aren’t durable enough to
handle and measure in a traditional sense. It isn’t possible to take a collagen print out of the liquid
bath it is in and measure it with calipers to determine how it matches up with the designed model.
Additionally, the prints aren’t stiff enough to hold their own weight in air, but tend to flatten out in
air and resume their original shape in an aqueous media. Therefore any physical means of simply
measuring the prints is not an option. Second, the printing process, as discussed in Chapter 3, is
generally done in a printing substrate such as a carbomer or the FRESH gelatin slurry. This limits
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visual feedback and doesn’t allow for on-the-fly changes to printing parameters. In conjunction
with this, the cross-linking process can slightly swell or shrink the print and give false feedback if
the operator doesn’t fully understand what is happening as the cross-linking happens. These two
problems make identifying sources of error and correcting them very difficult. To use an analogy,
bioprinting is like trying to make and bake bread using mechanical arms from the other room, and
the only visual feedback you have is through frosted glass. If you get a salty lumpy loaf you aren’t
sure if the problem is in the making or the baking or some combination of the two, you only know
the instructions you put in, and the final product that comes out. This is the challenge of parameter
optimization and resolution analysis in bioprinting.

4.1.2

Current Methods
The unique problems encountered in bioprinting discussed above have not yet been fully

solved, but techniques have been developed to address some of these issues. Investigation has been
done in detail on the viscoelastic properites of shear-thinning hydrogels, which includes collagen,
which helps to predict how these hydrogels will act when extruded and can be helpful in modeling bioprinting [65]. Characterization of a ceramic paste used in bone tissue scaffolds has been
characterized in detail by researchers, but this was using microscopic visual confirmation which
is not as useful when printing less solid pastes in a support substrate [66]. Other researchers have
developed a method to optimize parameters of hydrogels in a very quantitative way which shows
promise [15]. One proposed method is to use non-contact measurement devices like an MRI, but
a traditional 3-tesla MRI machine only has about a 1 mm resolution, which is not a fine enough
resolution when trying to print open channels in the 100 µm range.
A method to characterize 3D printed soft material constructs has yet to be developed. Such
would allow for printing parameters to be optimized by providing feedback on prints and iterating
print upon print. We set out to find a way to obtain feedback from the printing process to close the
loop on the printing feedback system and optimize and quantify the resolution capabilities of any
bioprinter.
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4.2

Gelatin Embedded Resolution Analysis
Initially, what was most needed was a method to measure the printed constructs and quan-

tify the resolution in some way. The first method we tried was based on the histological evaluation
of tissue slices. In histology, tissue samples are processed such that they can be thinly sliced and
then evaluated at the cellular level. We hypothesized that the same method could be utilized to
evaluate the printed constructs and measure open channels that were printed and quantitatively
define the resolution. The way that traditional histology is accomplished is with a series of dehydration steps where the existing medium in the tissue, starting with water, is slowly mixed with
another fluid, such as ethanol, that it is miscible with and replaces the first medium. This process
is then repeated with other materials until the tissue is finally imbued with a warm wax, which can
be cooled or frozen and sliced thinly. With help from the lab of Dr. Paul Reynolds, we attempted
to run our printed constructs through the same process as regular tissue. This method did not work
as the prints were too fragile to survive the entire process. The first time this was attempted only
small pieces of the original print survived, which was not sufficient to get a good evaluation of the
resolution. After some discussions and research we tried again using a more gentle dehydration
process used for the histological analysis of embryos which are fragile by nature. This process had
similar results and the printed constructs did not survive the process. This is because the prints
are very weakly cross-linked thermally and the collagen is not at all as strong as it is in native
tissue in this state. We tried simplifying the process even more and taking advantage of the porous
nature of the printed constructs, which were not nearly as dense as native tissue used in histology, so we hypothesized that the dehydration could be done in a single step. Finally we ended up
using a VWR Premium Frozen Section Compound which is miscible with water and freezes to a
consistency similar to wax that can be sliced via a cryostat. After printing and cross-linking, the
constructs were placed in a 50/50 mixture of water and the freezing medium for 4-6 hours and
then placed in a pure freezing medium bath for 24 hours in the refrigerator. This allowed sufficient
time for the water to be replaced by the freezing medium and for clean slices to be taken with the
cryostat. Cryostat sectioning then was done with slices tested from 50 - 200 µm. This method was
mildly successful, and with further refinement could be a method to consistently get resolution
feedback from bioprinted constructs, but there are several issues. First, it is very difficult if not
impossible to prevent distortions in the final slices due to the embedding process and the fragility
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of the slices after printing. What often occurred was that a good slice would be taken from the
embedded construct, but in the process of moving that slice to a glass slide, the sample would
become distorted in some way as the freezing medium melted.The print was not strong enough to
hold itself together and return to its original shape when it was sliced so thinly. Also, when a good
slice with minimal distortion was obtained, it was difficult to define the edges of the bioink. The
edges tended to be very ”fuzzy” and measurements could vary with 1-2 mm differences depending
on where a researcher chose to take the measurement. Lastly, the process was long and tedious,
and it took at least 24 hours to obtain results from a print and try another iteration on the printing
parameters. We concluded that although this method may work if it were refined and modified
further for this application, it was not useful and practical to obtain resolution measurements for
bioprinted constructs.

4.3

Raspberry Pi Camera Feedback System
While the gelatin embedded resolution analysis procedure was being investigated, we tried

several other methods of evaluating bioprints. One was a simple procedure to look at printed
and cross-linked prints under an optical microscope. A design shown in Figure 4.1.A called the
BioBenchy, because of its use as a benchmark for bioprinting parameter optimization, was used
which featured various shapes cut out in cookie-cutter fashion which created vertical channels of
different shapes and sizes. These were then visible through a microscope and could in theory be
measured and compared to the original design. Samples of pictures taken using this method are
seen in Figure 4.1.B.
The method seemed to work, but the particular objective in the available lab microscope
did not provide a wide enough field of view to obtain the images needed. Also, a consistent field
of view from a camera that provides a digital image would have been desirable over the manual
microscope that we had access to at the time. Modifications to the lab microscope were evaluated,
but a different approach proved to be more valuable and cost effective. Dr. Gregory Nordin,
when consulting on the cytotoxicity project discussed in Chapter 5, mentioned his lab making a
microscope from a Raspberry Pi camera and he was kind enough to give us some direction on
making our own. Using a Raspberry Pi and a plug-and-play camera attachment we were able to
design a camera system with which to evaluate bioprints. The camera system is seen in Figure
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4.1.C and is mounted to the bed of the bioprinter looking up. The camera sits horizontally and
the plane of the field of view sits at the bottom of the petri dish holding the substrate for printing.
The camera attachment for the Raspberry Pi features a focus lens, and with some trial and error
using a 3D printed case/stand the focus plane was set to the bottom of the petri dish so that when a
print is started, the first layer that is laid down is in focus. This turned out to be a good method to
evaluate bioprints, but was actually more useful than initially anticipated because it also allowed
for a live view of the first crucial layers of the bioprinting process. Figure 4.1.D shows what kind
of images could be obtained with this setup, and the videos were also of immense help. Seeing
that this method worked so well, we later invested in a small USB microscope which was also
used to do the resolution analysis. This allowed us to get exactly the images that we needed with
higher resolution than the Raspberry Pi camera could reasonably achieve. Example pictures with
the associated measurement analysis are shown in Figure 4.1.E-F. With this new feedback method
we were ready to establish a protocol that could ensure a bioprinter is repeatedly performing at its
optimal resolution, and what that resolution is.

4.4
4.4.1

Optimization Procedure
Slic3r Settings and Variables
The process of setting up a bioprint is fairly straightforward until the slicing stage. Initially

a CAD design is exported as an STL file, which is essentially an approximation of the CAD design
built from triangles. This STL file can then be imported into a slicing program. There a lot of
slicing programs out there, but one of the oldest and most advanced is called Slic3r which can be
downloaded at https://slic3r.org/. This slicing program takes the STL design and cuts it into 2D
slices that are stacked up to make the desired figure. The tool path is then calculated for each 2D
slice in the stack. There are quite a few parameters to consider in this process like how thin the
slices should be, how thick of an extrusion path do you use, how closely do you put two extruded
paths next to each other so that they bond without too much overlap? The optimization of these
parameters defines the resolution of the bioprinter. What makes this optimization particularly
difficult is that there is no available software that specifically deals with bioprinting on an in-house
device like ours. Commercially available bioprinters have their own software, but even that is not
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Figure 4.1: Camera Feedback System. A) Biobenchy design used as a benchmark for bioprinting resolution B) Lab microscope sample image of a bioprinted channel C) Raspberry Pi camera
system attached to printing platform, duct tape was used to attach it to the bed D) Example of
live images obtained from the camera system E-F) Biobenchy analysis using USB microscope and
measurements taken.

transferable to printers that run on different motherboards or have different extruder setups. The
Slic3r program we used is built for traditional 3D printers, and thus needs to be dealt with in a
unique way to work for bioprinting.
There are essentially eight parameters in the Slic3r software that need to be set, and four of
those need to be optimized for the particular bioink and printing substrate used. These parameters
essentially define the model of the cross section of the paste extrusion coming out of the needle tip.
Correctly optimized model parameters in the slicing software would match the slicer model with
what is really happening at the printer, and have the goal of lining up those extrusion just right so
that they bond to each other in a horizontal 2D layer and vertically layer upon layer. The parameters
are laid out in Table 4.1 with a brief explanation of what they do in the software and relate to in
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Table 4.1: Parameter Optimization Variables used in Slic3r
Variable
Extrusion Multiplier

Retraction Settings

Slice Height
Infill/Perimeter Overlap
Nozzle Diameter
Extrusion Width
Filament Diameter

Explanation
A scaling factor for the extruded volume after
the cross sectional volume is calculated. Used
to correct the width of the extrusion when the
calculated model is not accurate to reality
The amount the syringe plunger is pulled back
and then forward again to reduce the ”stringing”
effect that can happen during non-extruding
moves
The height of slices used by the slicing program
to approximate the model in 2D slices
A percentage overlap between the infill and
perimeters calculated in the slicing software
Inner diameter of the needle
Width of the extrusion used to calculate the volume of an extrusion
Diameter of the plunger or inner barrel of the
syringe

Status
Optimized

Optimized

Optimized
Optimized
Fixed
Fixed
Fixed

the printing process itself. Figure 4.2 is also supplied for a more visual representation of what the
parameters relate to. The parameters that need to be optimized are the Extrusion Multiplier, Slice
Height, Infill/Perimeter Overlap, and Retraction. The following procedure provides an opportunity
to systematically optimize and quantify each of these parameters.

4.4.2

Water Test - Extrusion Multiplier Baseline
The purpose of this test is a baseline Extrusion Multiplier that can be used in later tests. A

perfect printer and extruder system will have zero losses from the motor to the extruded bioink,
however that is almost never the case. Because mechanical losses exist in the gearing system from
the motor, flexing in the plastic of the syringe, slight compression in the bioink, and steps/mm
configurations errors in the motor firmware, the volume that is meant to be extruded from the syringe is not always true to what is intended. This test pushes a defined 0.5 mL of water out of
the syringe and tests to see how accurate the stock printer is in pushing that volume out. Then
the extrusion multiplier is changed over a range of values and the weight of the dish is recorded
to establish a relationship between the extrusion multiplier and the recorded weight. The correct
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Figure 4.2: Physical representation of variables used in Slic3r program

baseline extrusion multiplier can then be recorded and the printer will have a correct designed to
extruded volume ratio that accounts for losses in the system.

Procedure
1. Load test file and configuration settings
The STL file provided named ”0.5mLBox.stl” can be loaded into Slic3r as well as the .config
file provided to easily get the base settings needed for this test.
2. Update settings to reflect real needle and syringe
Several settings will need to be updated to reflect the needle and syringe sizes that are used in
the bioprinter being optimized. These setting can be seen by clicking on the ”Settings” menu
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and selecting each of the submenus to view them, ”Print Settings”, ”Filament Settings”, and
”Printer Settings”. The following pictures show what settings need to be changed. The Red
boxed values need to be changed to the inner diameter of the selected needle in mm, and the
Blue boxed values need to be changed to the diameter of the barrel/plunger of the selected
syringe. During these changes insure that the Extrusion Multiplier setting is set at 1.

Figure 4.3: Slic3r Water Test 1
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Figure 4.4: Slic3r Water Test 2

Figure 4.5: Slic3r Water Test 3
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Figure 4.6: Slic3r Water Test 4

3. Choose speed and slice file
After the settings are updated to reflect the real needle and syringe values, a speed can be
chosen to print. This will make no difference in the test results and a speed faster than would
normally be used to print, 10-20 mm/s is recommended to save time in the printing process.
Slice the file.
4. Setup printer and petri dish, print file
Get printer set up as normal and print using a 35 mm petri dish. A larger dish may be used,
but this print is designed to fit inside this size dish. Fill the printing syringe with water and
mount in the printer. Attach the needle and prime the needle such that water is just at the tip
of the needle. If there is air in the needle and it is not primed the test will give false results.
Weigh the petri dish and record the weight. Fit the dish in position on the printer. Load and
print the sliced file.
5. Weigh dish with print
After the print finishes, quickly weigh the dish and record the weight. Convert the weight to
a volume assuming the density of water.
6. Repeat steps 2-7 until a wide range of data is obtained
45

At this point two methods can be followed. The quickest approach is to simply find the Extrusion Multiplier where the extruded volume matches the designed volume of 0.5 mL. This
will require guessing a new Extrusion Multiplier repeating the test to see if the new value
is closer in terms of the extruded volume. Repeat tests until the extruded volume matches
the designed. A more detailed method can be performed where the extrusion multiplier can
be varied over a range of values, 0.2 - 1.3, and plotting the recorded extruded volumes with
their associated extrusion multipliers. This will provide a plot where the baseline extrusion
multiplier can clearly be determined as shown in Figure 4.7.
Once determined, this baseline extrusion multiplier can give users an idea of how much loss
there is in their printer/extruder system and where the Extrusion Multiplier provides a 1:1 ratio of
the designed/extruded volume. Once optimized the baseline Extrusion Multiplier value can be
input into Slic3r in the Filament Settings > Filament > Filament section. This parameter is only
printer and equipment dependent, and therefore is valid for any bioink/substrate used. However,
different syringes may need to be done separately because of possibly different losses within the
syringe and plunger.

4.4.3

Retraction - Clean Starts and Stops
The retraction parameter moves the plunger of the syringe back slightly when non-extruding

movements are made to prevent a common problem in 3D printing known as ”stringing”. This happens when the tool tip is moved from a location where it had been extruding to a new location, and
on the way no extrusion is desired. If no retraction is done, then a spiderweb like strings tends
to string from the nozzle tip and creates small undesirable imperfections in the print. In this step,
the retraction setting is optimized by printing four parallel lines and changing the setting until the
starts and stops of the lines are clean with no stringing. To successfully perform this step the user
will need to have some familiarity with gcode. Gcode is the language that 3D printers and CNC
machines run on and is quite simple to learn. Good online tutorials are available.

Procedure
1. Load provided gcode file in editor
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Figure 4.7: Baseline Extrusion Multiplier water test graph. The Extrusion Multiplier was varied
through known values and the resultant volumes of extruded water were recorded. The graph
provides a relationship between the Extrusion Multiplier and the extruded volume which should
be linear. The baseline Extrusion Multiplier was then found by matching the Extrusion Multiplier
where the 0.5 mL extruded volume was found.

Load the provided gcode file titled ”retraction.gcode” into a text editing software. Notepad++
is recommended and can be downloaded for free, but other text editors will work as well. At
the top of the code in lines 4-6 there are three variables named Extrusion Amount, Retraction, and Prime. These variables are just placeholders for the values currently in the code and
will need to copied to the rest of the code using the Find and Replace function when they are
later changed. The Extrusion Amount is a default value based on an Extrusion Multiplier,
found in the previous step, of 1.05. This value may need to be changed depending on the
previously found baseline Extrusion Multiplier. In the end it simply needs to be extruding
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enough to print a good solid line, the fine details of the Extrusion Multiplier won’t affect
this test. The other two variables, Retraction and Prime, are the current values that are found
within the rest of the code for the distance the plunger is retracted before a non-extruding
move (Retraction) and the distance the plunger is moved forward again when an extrusion is
about to start (Prime). The values here will work initially but are the values that need to be
optimized in this step.
2. Print initial test
Set up a 35 mm petri dish on the print platform and center it such that the needle is at the
center of the dish and zeroed at the bottom of the dish. The distance between the bottom of
the needle and the petri dish is important to get right and consistent. Slide a piece of paper
underneath the needle and move the print bed until there is some resistance from the paper
when it is moved underneath the needle tip. This creates the appropriate gap between the
needle and the petri dish. The print can then be started by loading the gcode file. Other
modifications may need to be made to the file depending on your print settings, but that will
be dependent on the printer and will require a good knowledge of gcode to adapt.
3. Evaluate test and change parameters
Figure 4.8 shows what an unoptimized vs optimized test looks like. Repeat steps 1-2 until
the test has clean starts and stops with no stringing as shown in the figure. This can be done
without the camera setup described above, but is made easier with it. Record the optimized
retraction and priming values.
By optimizing these retraction settings, stringing will be eliminated or minimized which
creates cleaner prints and predicable results. Copy the optimized values in to Slic3r in the Printer
Settings > Extruder > Retraction section. The ”Length” value correlates with the Retraction
setting, and ”Extra length on restart” is the Prime value. These settings are dependent on the
syringe, needle, and the bioink used and will need to be optimized for each combination.
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Figure 4.8: Retraction settings optimization results. Four paralell lines test for clean starts and
stops. Left: Un-optimized settings, red shows residual stringing. Right: Optimized settings which
show clean lines with no stringing.

4.4.4

Extrusion Multiplier - Solid 2D Layers
This step ensures that solid 2D layers are being formed by changing the Extrusion Mul-

tiplier from the baseline value. The reason that this value needs to be changed is because of the
shape of the cross section that is being extruded from the needle tip. The assumption in the slicing
software is that the cross section is circular with the same diameter as the inner diameter of the
needle. This however is not often the case because of the attraction of the bioink to the needle.
Metal needles are highly wettable and the bioink, which is aqueous, tends to climb up the needle slightly which shifts some of the extruded volume upwards and creates a thinner cross section
than intended. The Extrusion Multiplier then has to be increased to compensate. However, some
bioinks, like alginate, tend to require a much smaller Extrusion Multiplier than the baseline value
when optimizing using this method. This is thought to be because of the swelling nature of the
alginate when it cross-links, but more research should be done to investigate the phenomenon.
In this step a print speed should be chosen that will remain consistent for the combination
of needle, syringe, bioink, and printing substrate chosen for this optimization. The print speed
affects the cross sectional area because a faster print speed will not allow the bioink to climb the
needle as much as a slower print speed and will result in a flatter cross sectional area. Figure 4.9
shows simple Reynolds number calculations that vary the fluid velocity through the needle with the
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Figure 4.9: Reynolds Number calculations as a function of fluid velocity through various needle
sizes and for various bioink viscosities. A print speed should be chosen that is within the laminar
region so that the cross section of the extrusion is predicable.

corresponding Reynolds number for various needle diameters and bioink viscosities. This should
help users get an idea of how their particular needle size and bioink affect the print speed they
should be using. The fluid velocity should always be kept in the laminar region to ensure that
the extruded cross section is predictable. The print speed is not shown on the graphs, but for a
predicable cross section, should match the fluid velocities coming from the tip of the needle. We
have found that 10 mm/s tends to be a safe speed for most bioinks. Whatever speed is chosen, be
sure to record it and keep in mind that speed is attached to the optimized parameters determined in
this step.
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This step is best done with the camera system discussed above. This is because depending
on the particular bioink and printing substrate combination used, the finished print may distort
or the bioink may diffuse slightly before the print can be evaluated. The camera system allows
live video/pictures to be taken and parameters can often be updated via intuition from watching
the print even before it finished printing. However, the camera system is not necessarily required.
The prints should also be allowed to finish printing and cross-linked to ensure that a solid layer is
formed after the cross-linking process and the prints could be evaluated.

Procedure
1. Load the provided file and print
Load the provided STL file named ”SingleLayerBox.stl” and slice it according to the default
settings that were optimized in the previous steps. It should be a single layer box that fits
within a 35 mm petri dish. Whether the box slices as a single layer will depend on the
set layer height. Change the layer height up so that a single layer is shown in the slicing
viewport. The infill should be at 100%. Slice and export the file as gcode and print. Make
sure the needle tip is centered at the bottom of the 35 mm petri dish. Choose a speed as
discussed above and make sure that all values in the Slic3r Print Settings > Speed > Speed
for print moves and Modifiers sections have that speed recorded. Set up printer and petri
dish with the printing substrate and print.
2. Evaluate print and update parameter
After printing evaluate the printed layer. This can be done with the camera system as discussed, manually by observing the bottom of the petri dish after printing, or observing after
cross-linking. Any of these methods are adequate, but the fastest method would be using
the camera system. After the print is evaluated, determine if/how the Extrusion Multiplier
should be changed to create a solid single layer. This should be the lowest value of the Extrusion Multiplier that forms a solid layer so that a clean surface finish can be obtained and
the printer is not overextruding. An example of what should be observed in a solid layer
is shown in Figure 4.10, this includes parallel lines that just touch/overlap or the boundary
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Figure 4.10: Extrusion Multiplier optimization results, Left: un-optimized single layer box print,
the red shows void space that will not allow the 2D layer to bond well. Right: Optimized print,
much less void space, blue region shows extrusion lines that have blended such that there is no
longer a distinction between them.

between them disappears altogether. However, the most definitive test is done post-crosslinking so that the swelling of the print can be accounted for and all the extrusions can be
seen to bond to each other.
3. Optional parameter - Infill/Perimeter Overlap
During this test it may be observed that the infill bonds well together as well as the perimeter to itself, but there is a gap between the two. This can be solved by changing the Infill/perimeters overlap value found in Slic3r under Print Settings > Advanced > Overlap.
Record the optimized Extrusion Multiplier value and copy it into Slic3r in Filament Settings
> Filament > Filament. This parameter is valid only for the particular needle size, syringe, bioink,
and printing substrate tested.

4.4.5

Slice Height - Combining Layers
The last parameter to optimize the Slice Height which is a reflection of the height of the

cross sectional area that is being extruded, accounting for some overlap so that layers bond well.
This is the most difficult parameter to optimize because it is difficult to observe. There are several
ways to test and optimize this parameter, but they all tend towards a subjective visual evaluation
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vs a quantitative measure as can be done using the camera system in the other steps. This is a less
desirable method of evaluation, but with some practice and a few steps the Slice Height value can
correctly be obtained.

Procedure
1. Load provided STL file and print
Load the provided STL file named ”SliceHeight.stl” into the slicing software. The model
can be seen in Figure 4.11 and features a stair step pattern where individual layers can be
seen and then tested to see if the layers bond to each other. Once loaded this file will need
to be manipulated slightly to get the layers right from the slicing software. The end goal is
to have each of the steps be a single sliced layer by scaling the print vertically (only in one
dimension) and changing the Slice Height parameter in Slic3r under Print Settings > Layers
and perimeters > Layer height. Make sure the ”layer height” and the ”first layer height”
match each other. An inconvenient quirk of Slic3r is that for the correct cross section to be
modeled, the Layer Height and the Nozzle Diameter parameters need to be kept the same.
This means that when changing the Layer Height in this step, the Nozzle Diameter also needs
to be changed to match. This defeats our original purpose of using the real needle diameter
in the first step, but this is the only way to maintain the modeled cross section. The Nozzle
Diameter parameters are under the Printer Settings > Extruder > Size section. Once this is
done the file can be exported and printed as usual.
2. Evaluate print and update parameter
After the print is finished, allow it to cross-link and evaluate it for layer upon layer adhesion.
If the layer height is too small the surface will be bumpy and not clean, too large and the layers won’t bond to each other. When changing the Layer Height parameter, be sure to change
the Nozzle Diameter as well to match. Repeat printing process until the optimal layer height
is achieved. Record for use in Slic3r.
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Figure 4.11: Slice Height optimization step model, features a single layer stair step design where
single layer slices are printed with slight overlap to see the adhesion between layers and if a good
layer Slight Height parameter has been reached.

3. Optional - Print tall box
Another method to get the layer height is to print a tall box and observe the surface of the
box and whether it has a concave or convex nature. This is an easy to observe phenomena,
but takes longer to printer and more bioink is necessary to run the print itself.
After the Layer Height parameter is optimized the Layer Height and Nozzle Diameter can
be changed in Slic3r. This parameter is valid only for the particular needle size, syringe, bioink,
and printing substrate chosen in the test. It would also be logical to re-optimize the Extrusion
Multiplier in the previous step since the Nozzle Diameter was changed here. In our experience this
does not change the optimized Extrusion Multiplier much, but may have a slight effect.

4.4.6

Conclusion
With the previous step, a bioprinter can be optimized to achieve its highest possible resolu-

tion. That resolution is, however, hard to quantify exactly, and may be best expressed in the lumen
diameter that can be printed. Most 3D printer motors have a resolution around 100 µm, however,
the needle diameter will have the largest influence on the resolution of the printer overall as its
diameter is typically around 100-500 µm. The reportable resolution of the printer will depend
on these two parameters as well as the bioink and the printing substrate. A bioink that does not
cross-link well will not be able to hold its shape well and reliably have clearly open lumens of a
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particular size. It has been observed in our research however that <1 mm diameter lumens are
achievable and within reach of an optimized desktop bioprinter.
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CHAPTER 5.
3D PRINTED MICROFLUIDIC CELL CULTURE: CYTOTOXICITY
AND CELL ADHERENCE ANALYSIS FOR PEGDA RESINS

5.1
5.1.1

Background
3D Printing Microfluidics
Microfluidic, Lab-on-a-Chip, devices are one method by which complex cell-based re-

search can be simplified from a multi-step process to a single manageable step. Applications
include stem cell analysis, cell-drug interactions, and as 3D cellular scaffolds as demonstrated
by various researchers [67–72]. Biosensing devices have also recently been developed using microfluidic devices for preterm birth biomarkers [73]. However, manufactring of these devices is
an expensive and slow process. Currently, commercially available off the shelf microfluidic devices compatible with cell culture cost anywhere from $150 to over $2000 (https://mimetas.com,
https://alineinc.com). Polydimethyl siloxane (PDMS) is used in microfluidic devices with cell
culture to make custom devices in the lab, but the fabrication process for these devices is slow
(hours to days depending on complexity). Typically manufacturing custom PDMS devices uses
cleanroom processes and molding (i.e., soft-lithography). PDMS has been extensively studied for
cell culturing in microfluidic devices and its associated advantages and challenges have been elucidated [74]. Additionally, Lung-on-a-Chip [75] and Kidney-on-a-Chip [76] microfluidic devices
have been made with PDMS and show promise in their respective applications with microfluidic
cell culture, but the manufacturing of these devices in-house is a slow process.
3D printing allows for the rapid fabrication of complex geometries, and the Nordin lab
at Brigham Young University has shown that 18 µm x 20 µm cross section channels can be obtained using a specialized DLP 3D printer and associated resin [13]. The poly(ethylene glycol)
diacrylate (PEGDA, MW258) resin currently used in this printer includes a 1% (w/w) Irgacure 819
photoinitiator and a 2 % (w/w) 2-nitrophenyl phenyl sulfide (NPS) UV absorber. PEG itself is a
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polymer well-suited for biological use given its native non-immunogenicity [77]. However, for use
in biological applications, the photoinitiator and UV absorber require cytotoxicity analysis.
In this study, the photoinitiator Irgacure 819 and two different UV absorbers were tested
in the PEGDA resin to evaluate their cytotoxic and cell-adherence properties. This study also
evaluates post-processing methods to leech out cytotoxic species, thereby dramatically reducing
the material’s cytotoxicity.

5.2

DLP Microfluidic 3D Printer
The 3D printer used in this paper is described in References 13,78,79. It has a 385 nm LED

light source and a pixel pitch of 7.6 µm in the projected image plane. We used a custom photopolymerizable PEGDA (PEGDA, MW258) resin as described above. Details about the development of
this resin, and the motivation behind its formulation to produce the smallest stereolithographically
3D printed channels reported to date, are provided in Ref. 13.
We used 25 mm square silanized glass slides as 3D printing substrates. Slides were first
rinsed with acetone and isopropyl alcohol (IPA), and then immersed in toluene mixed with 10%
3-(trimethoxysilyl)propyl methacrylate for 2 hours. After silanization, we stored the glass slides
in fresh toluene inside a closed container until use, which ranged from under an hour to several
weeks. All 3D prints reported in this paper were fabricated with a layer thickness of 10 µm. The
image plane irradiance was 21.2 mW/cm2 with an LED source spectrum as reported in [13] with a
peak at 383 nm.
The design was a cylinder with a diameter of 13.1 mm and an average thickness of 146 µm
as shown in Figure 5.1. It is worth noting that the printed chips were not perfectly circular, but cut
along a chord on one side because of the 12 mm width of the available print bed. After printing,
samples were flushed with IPA prior to optical curing, which consisted of a 30-minute exposure in
a custom curing station using a 430 nm LED (Thorlabs, Newton, New Jersey) having a measured
irradiance of 11.3 mW/cm2 in the curing plane. After curing, the samples were soaked in DI water,
which enabled them to be more easily separated from their glass substrates using a razor blade.
The samples were then allowed to dry in air prior to use.
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Figure 5.1: 3D printed PEGDA substrates for cellular cytotoxicity and adherence testing

5.3

Cytotoxicity Testing
The PEGDA material was tested using a direct contact technique as outlined in ISO 10993-

5, which consisted of growing a cell layer on tissue-culture polystyrene (TCPS) and placing the
material being tested on top of the cell layer. After 24 hours, the cells were stained with a Calcein
AM/Ethidium homodimer live/dead assay (Biotium Inc.) and imaged to detect changes indicative
of cytotoxicity. Stained cells were imaged using a FLoid Cell Imaging Station (Life Technologies)
and images were analyzed and viability assessed using CellProfiler (CellProfiler.org). According to
ISO 10993-5, a cell response was considered cytotoxic if there was a 30 % decrease in surface area
coverage versus a control. Initial testing showed that the as-printed NPS PEGDA polymer, induced
a severe cytotoxic response from the cell layer as seen in Figure 5.2.b. For initial cytotoxicity
investigations, PEGDA substrates were printed with no UV absorber added, thus isolating the
cytotoxic response from the photoinitiator Irgacure 819, and when tested with cells, no cytotoxic
response was seen. It was thus concluded that the cytotoxic element of the resin was the UV
absorber and cytotoxicity tests were performed with resin containing the UV absorbers.
PEGDA substrates were then printed using the Irgacure 819 photoinitiator and two different UV absorbers. NPS was used in prior publications [13, 78–80] and has been demonstrated
to produce good prints with very high resolution, as mentioned above. Cytotoxicity tests were
performed the the NPS containing resin with EA.hy926 cells (ATCC CRL-2922), an endothelial
cell line, which were grown and passaged according to protocols established by the manufacturer.
These cells were chosen over a primary or stem cell line because of their ease of use and low cost
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of maintenance. This cell line is likely less sensitive to cytotoxicity than other cell lines, but the
results show general cell behavior in the presence of strong cytotoxic contaminants. To leech out
the cytotoxic constituents in the polymer,namely NPS the UV absorber, both water and ethanol
were tested as possible eluents. DI water was chosen because of the nature of PEGDA and its
common use as a hydrogel. It was also determined that 200 proof ethanol was a good eluent candidate given the higher solubility of NPS in ethanol and for its ease of use. Washing of the PEGDA
substrates was done for up to 96 hours. Given the low solubility of the contaminants in water, the
distilled water was changed out every 24 hours in order to not saturate the solution. Ethanol was
not changed out during the washings.
The washed PEGDA substrates were then tested for cytotoxicity using the direct contact
method and were stained using the Calcein AM/EthD live/dead assay and imaged for evaluation
of fractional cell surface coverage. Results are given in Figure 5.2, which shows the fractional
surface coverage of cells normalized to TCPS seeded at the same cell density. Eluent tests showed
that the 3D printed PEGDA resin containing NPS as a UV absorber could be made non-cytotoxic
by an eluent wash. A DI water wash showed that after 48 hours the level of NPS in the substrate
was reduced such that the substrate did not induce a cytotoxic response as shown in Figure 5.2b.
However, the ethanol wash proved to be more effective and achieved a non-cytotoxic response after
only a 12-hour wash, as seen in Figure 5.2a. Washing with ethanol or water demonstrates that the
PEGDA resin with the NPS UV absorber can be made non-cytotoxic with a simple post-processing
step. However, these wash times are only applicable for the specific cylindrical geometry of the
tested substrates. We expect that wash times will increase for thicker prints and/or microfluidic
channels in a device will need to be washed with flowing eluent.
Since the PEGDA resin with NPS UV absorber required post-print processing to combat
cytotoxicity, and this is ultimately undesirable, another UV absorber was tested to ascertain if a
resin could be made that required no post-print processing. Avobenzone is a UV absorber found in
commercially available consumer products such as sunscreen. A PEGDA resin with this UV absorber was made at the same 1% Irgacure 819 photoinitiator concentration but with 0.38% avobenzone, which creates comparable absorption as 2% NPS because of its higher molar absorptivity.
This resin formulation was tested for its cytotoxicity by the same direct contact method as the prior
resin. As seen in Figure 5.2c, the avobenzone resin, with no post-processing, showed no signs of
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Figure 5.2: (a) Cytotoxicity of NPS UV Absorber with Eluent Wash: Data were normalized against
a TCPS control seeded at the same density. A non-cytotoxic response, considered if greater than 70
%, was achieved using water after a 48 hour wash time, while if using ethanol only 12 hours was
required. (b) Stained EA.hy926 cells undergoing cytotoxicity testing with resin containing NPS
UV absorber. Both the initial untreated and 4-hour ethanol wash resins are shown. (c) Stained
Ea.hy926 cells undergoing cytotoxicity testing with untreated resin containing avobenzone UV
absorber. (d) stained EA.hy926 cells used as a control on TCPS.
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cytotoxicity compared to a TCPS control, demonstrating that it is non-cytotoxic as-printed, and
thus is a more attractive resin candidate for cell-based studies.

5.4

Cell Adherence
Note that the cytotoxicty testing does not give any information about cell adherence to 3D

printed PEGDA. We therefore performed adherence testing on the PEGDA substrates with TCPS
as a control to see how well anchoring proteins secreted from the cells adhered to the PEGDA material. After printing with either the NPS or avobenzone UV absorber, the substrates were sterilized
and were placed in a sterile 12-well plate. Endothelial cells (EA.hy926) were then passaged into
the wells of the 12-well plate such that the cells could attach and proliferate on the PEGDA material. The cells were viewed after a 24-hour exposure time and stained using a Calcein AM/EthD
live/dead assay. Adherence was measured by image analysis using CellProfiler and calculating the
fractional cell surface coverage of the adherent cells in comparison to the TCPS control which was
passaged at the same cell density. Initial testing showed that the cells did not adhere well to the
printed PEGDA material in its native state, even after previously discussed eluent treatments were
performed to reduce the cytotoxicity of the materials. This is in harmony with various research
groups reporting on the known overall protein-repellant nature of untreated PEG [81, 82]. It was
apparent that further post-processing was needed to modify the PEG surface for protein adsorption
and cell adherence on the PEGDA substrates. It is worth noting that these surface modifications
will need to significantly increase protein adsorption in order for cells to remain adhered during
the shear stress experienced in microfluidic channel lumens. This and other cell stressors in microfluidic devices are well summarized by Varma and Voldman [83].
Several surface modifications were attempted to allow for adherence of proteins to the
PEGDA surface including a topographical modification and oxygen plasma treatment. Topographical modification and micropatterning has been shown to be effective in helping cells that adhere
weakly to PEG have access to increased surface area and thus have a higher chance of adhering
to the surface [81]. A simple topographical modification of small parallel channels (width: 20
µm, depth:10 µm, spacing: 20 µm) was attempted with little improvement over the unmodified
surface.
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Figure 5.3: (a) Adherence of EA.hy926 cells to PEGDA test materials with different UV absorbers.
Data are shown as the fractional surface coverage of the cells normalized to a TCPS control. These
data suggest that after treatment with plasma, the materials allow the adherence of cellular proteins
at a level similar to TCPS. (b) Image of adhered and stained EA.hy926 cells after plasma treatment
on avobenzone and NPS resins.

Oxygen plasma treatment has also been shown to increase cellular adherence on PEGDA
[14]. For this application, plasma treatment was chosen as a simple surface modification to allow for the attachment of cellular proteins. Another surface modification includes the addition of
membrane proteins to the PEG and may be useful in later work if additional cellular adherence
is needed [84]. For the plasma treatment, a Harrick Plasma Cleaner (Model PDC-32G) was used
with standard lab atmosphere, not pure oxygen. The treatment was performed for 1-2 minutes. After plasma treatment, the substrates were sterilized and tested according to the procedure outlined
above. Testing showed that the plasma treatment worked well to enhance cell attachment. This
resulted in cell adherence at an average of 96% for the avobenzone, and 85% for the NPS UV absorber in comparison to a TCPS control as seen in Fig 5.3a. Therefore, a simple plasma treatment
was sufficient to modify the PEGDA surface such that proteins were able to adhere to the surface
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and allow for cell attachment. Further, the cell attachment to the avobenzone chips was statistically
indistinguishable from the TCPS control, which bodes well for its further use in microfluidic cell
culture.

5.5

Conclusion
In this study, a 3D printed resin consisting of PEGDA with 1% (w/w) Irgacure 819 with

two different UV absorbers was tested for its cytotoxic properties with an endothelial cell line
(EA.hy926). NPS, the first UV absorber tested, required a 12-hour post-printing ethanol wash to
leech out cytotoxic contaminants in the material and afterward did not induce a cytotoxic cellular
response when tested using the direct contact method outlined in ISO 10993-5. Avobenzone, the
second UV absorber tested, did not require any post-print processing for cell compatibility.
Cell adherence was also tested for each PGEDA resin containing the different UV absorbers. Results showed that with a plasma treatment, both the NPS and avobenzone containing
resins could support cell adhesion and in particular, the avobenzone containing resin was indistinguishable from TCPS controls. These tests show that 3D printed microfluidic devices can, with a
few simple post-printing steps, be nontoxic to cells and allow for good cell adhesion in preparation
for use in Lab-on-a-Chip applications.
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CHAPTER 6.

6.1

CONCLUSIONS AND FUTURE WORK

Conclusions
This thesis details how a bioprinting system was developed with four main conclusions.

First, it was shown that a bioprinting system could be developed cheapy ( $1000) from a commercially available 3D printer. Custom modifications can be made to suit the needs of researchers and
the ever changing needs of bioprinting. Second, a collagen-based dECM bioink was developed
that can provide a cheap and modifiable bioink for researchers to start from in developing bioink
for tissue engineering applications. Third, a procedure for optimizing bioprinting parameters was
developed using open-source software and a Raspberry Pi camera feedback system. Lastly, procedures were developed to make two resins with different UV absorbers, that are compatible with
cells and able to be used in Lab-on-a-Chip applications.

6.2

Future Work
To continue this work, one of the next necessary steps will be to test the cytotoxicity and

ability of the dECM bioink to allow for cell proliferation. The bioink will need to be reliably sterilized and tested with cells to see how they grow and if additional modifications need to be made.
Following these cell tests, the printing of a vascular network would be an important benchmark.
Channels of various diameter could be printed parallel to each other and with vascular promoting
cells inlaid, such as smooth muscle cells or fibroblasts, and growth factors like VEGF, a vascular
network could be made and tested to optimize the many variables that will come into play. The
development of a vascular network will allow for the true testing of 3D cell culture and possibly
aid in the progression towards a true artificial tissue.
Another avenue of future work involves the modeling of the bioprinting process. This
could consist of the modeling of the bioink being extruded into the substrate and the subsequent
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diffusion of the bioink before cross-linking. The slicing of a desired CAD model could then be
optimized and slicing parameters modified that would allow for the modeled extrusion of the bioink
to produce the desired structure. This would truly optimize the resolution of bioprinters and allow
researchers to see where the limit of resolution lies.
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